An Open Label Extension Study of STX209 in Subjects With Autism Spectrum Disorders

NCT01064973 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
32
Enrollment
INDUSTRY
Sponsor class

Stopped all active subjects were rolled into study 209AS209/NCT01706523

Conditions

Interventions

Sponsor

Seaside Therapeutics, Inc.